Amanote Research
Register
Sign In
Changes to the Migratory Inhibitory Factor, IL-17, and IL-10 Levels in Serum From Chronic Hepatitis B Patients and Clinical Significance Following Baraclude® Treatment
Genetics and Molecular Research
- Brazil
doi 10.4238/2015.april.13.16
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Genetics
Molecular Biology
Date
January 1, 2015
Authors
X.-H. Yu
J.-C. Zhang
X.-Y. Li
T. Chen
Publisher
Genetics and Molecular Research
Related search
Serum IL-33 Levels Are Associated With Liver Damage in Patients With Chronic Hepatitis B
Journal of Interferon and Cytokine Research
Medicine
Virology
Immunology
Cell Biology
Serum Cytokine of Il-2, Il-10 and Il-12 Levels in Patients With Stomach Adenocarcinoma
Arquivos de Gastroenterologia
Gastroenterology
Serum Levels of IL-33 and Correlation With IL-4, IL-17A, and Hypergammaglobulinemia in Patients With Autoimmune Hepatitis
Mediators of Inflammation
Immunology
Cell Biology
IL-17 and IL-11 GCF Levels in Aggressive and Chronic Periodontitis Patients: Relation to PCR Bacterial Detection
Mediators of Inflammation
Immunology
Cell Biology
Serum Levels of Interleukin 10 (IL-10) in Patients With Type 2 Diabetes
Clinical Biochemistry
Medicine
Clinical Biochemistry
Simvastatin Suppresses Airway IL-17 and Upregulates IL-10 in Patients With Stable COPD
Chest
Cardiology
Critical Care
Cardiovascular Medicine
Intensive Care Medicine
Pulmonary
Respiratory Medicine
IL-27 Regulates IL-10 and IL-17 From CD4+ Cells in Nonhealing Leishmania Major Infection
Journal of Immunology
Allergy
Immunology
Serum Cytokine of IL-10 and IL-12 in Chronic Liver Disease: The Immune and Inflammatory Response
Disease Markers
Biochemistry
Medicine
Clinical Biochemistry
Molecular Biology
Genetics
Aqueous and Serum Interferon Γ, Interleukin (IL) 2, IL-4, and IL-10 in Patients With Uveitis
Archives of Ophthalmology
